Summary
To clarify the biochemical markers to discriminate between nonalcoholic steatohepatitis (NASH) and simple steatosis in Japanese patients and to clarify the clinicopathological features of NASH, we analyzed patients with NASH and simple fatty liver (FL). Seventy-five patients with biopsy-proven NASH and 53 patients with biopsy-proven FL were enrolled. Their clinical characteristics and histological findings were compared. Detection of GB virus (GBV) RNA and SEN virus (SENV) DNA was performed by polymerase chain reaction (PCR). Mutational analysis of the HFE gene was performed by PCR-restriction fragment length polymorphism. As a marker of oxidative stress, serum thioredoxin (TRX) levels were determined. Insulin resistance was evaluated by a homeostasis model assessment of insulin resistance (HOMAIR). Serum TRX levels were significantly elevated in patients with NASH, compared with patients with FL. GBV was detectable in the serum of only one patient with NASH. SEN virus was detected in 50% (15/30) of the patients tested, but the prevalence was not significantly different between the two groups (42% [8/19] in FL and 64% [7/11] in NASH). The HFE gene was not detected in any patient.We constructed a receiver operating characteristic (ROC) curve which confirmed that serum TRX and ferritin levels were predictors for distinguishing NASH from FL. HOMA-IR was higher in NASH patients than in FL patients. The pathogenesis of NASH may be associated with insulin resistance and iron-related oxidative stress. The serum TRX level is a parameter for discriminating NASH from simple steatosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Sanyal AJ (2002) Technical review on nonalcoholic fatty liver disease. Gastroenterology 123: 1705–1725
Younossi ZM, Diehl AM, Ong JP (2002) Nonalcoholic fatty liver disease: an agenda for clinical research. Hepatology 35: 746–752
Powell EE, Cooksley WGE, Hanson R, Searle J (1990) The natural history of nonalcoholic steatohepatitis: a follow-up study of 42 patients for up to 21 years. Hepatology 11: 74–80
Day CP, James OFW (1998) Steatohepatitis: a tale of two ‘hits’? Gastroenterology 114: 842–845
James O, Day C (1999) Non-alcoholic steatohepatitis: another disease of affluence. Lancet 353: 1634–1636
George DK, Goldwurm S, Macdonald GA (1998) Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis. Gastroenterology 114: 311–318
Hirota K, Matsui M, Iwata S (1997) AP-1 transcription activity is regulated by a direct association between thioredoxin and Ref-1. Proc Natl Acad Sci USA 94: 3633–3638
Nakamura H, Nakamura K, Yodoi J (1997) Redox regulation of cellular activation. Annu Rev Immunol 15: 351–369
Linnen J, Wages J Jr, Zhang-Keck ZY (1996) Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271: 505–508
Simons JN, Leary TP, Dawson GJ (1995) Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1: 564–569
Kiyosawa K (1997) Non-alcoholic steatohepatitis and GB virus-C/hepatitis G virus infection: is there a causal relationship? Intern Med 36: 236–237
Nishizawa T, Okamoto H, Konishi K (1997) A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 241: 92–97
Tokita H, Murai S, Kamitsukasa H (2001) Influence of TT virus on the histopathological features of nonalcoholic fatty liver disease. Hepatol Res 19: 197–211
Primi D, Fiordalisi G, Mantero JL, Identification of SENV genotypes. International patent number WO0028039 (international application published under the patent cooperation treaty). http://ep.espacenet.com
Tanaka Y, Primi D, Wang RYH (2001) Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 183: 359–367
Umemura T, Yeo AET, Sottini A (2001) SEN virus infection and its relationship to transfusion-associated hepatitis. Hepatology 33: 1303–1311
Brunt EM, Janney CG, DiBisceglie AM (2000) Nonalcoholic steatohepatitis: a proposal for grading and staging the histologic lesions. Am J Gastroenterol 94: 2467–2474
MacSween RNM, Anthony PP, Sheuer PJ (1987) Pathology of the liver. Churchill Livingstone, Edinburgh, p 185
Tan D, Matsumoto A, Conry-Cantilena C (1999) Analysis of hepatitis G virus (HGV) RNA, antibody to HGV envelope protein, and risk factors for blood donors coinfected with HGV and hepatitis C virus. J Infect Dis 179: 1055–1061
Kazemi-Shirazi L, Datz C, Maier-Dobersberger T (1998) The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C. Gastroenterology 116: 127–134
Matteoni CA, Younossi ZM, Gramlich T (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116: 1413–1419
Bacon BR, Farahvash MJ, Janney CG (1994) Nonalcoholic steatohepatitis: an expanded clinical entity. Gastroenterology 107: 1103–1109
Sumida Y, Nakashima T, Yoh T (2003) Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 38: 32–38
Angulo P, Keach J, Batts K (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30: 1356–1362
Mendler M, Turlin B, Moirand R (1999) Insulin resistance-associated hepatic iron overload. Gastroenterology 117: 1155–1163
Sohda T, Yanai J, Soejima H (1999) Frequencies in the Japanese population of HFE gene mutations. Biochem Genet 37: 63–68
Loguercio C, Girolamo V, Sio IF (2001) Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects. J Hepatol 35: 568–574
Powell EE, Kroon PA (1992) Liver, lipoproteins and disease: II. Clinical relevance of disordered cholesterol metabolism in liver disease. J Gastroenterol Hepatol 7: 225–231
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Tokyo
About this paper
Cite this paper
Okanoue, T., Yamauchi, N., Furutani, M., Hirohama, A., Sumida, Y., Nakashima, T. (2005). Predictors of Nonalcoholic Steatohepatitis in Japanese Patients: Thioredoxin and NASH. In: Okita, K. (eds) NASH and Nutritional Therapy. Springer, Tokyo. https://doi.org/10.1007/4-431-27172-4_5
Download citation
DOI: https://doi.org/10.1007/4-431-27172-4_5
Publisher Name: Springer, Tokyo
Print ISBN: 978-4-431-21388-8
Online ISBN: 978-4-431-27172-7
eBook Packages: MedicineMedicine (R0)